Navigation Links
Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
Date:8/5/2008

ns except for the four endocrine hormones licensed to Schering-Plough.

ABOUT MODIGENE

Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit http://www.modigeneinc.com.

Safe Harbor Statement: This press release contains forward-looking statements, including statements regarding the results of current studies and preclinical experiments and the effectiveness of Modigene's long-acting protein programs and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect Modigene's business and prospects, including the risks that Modigene may not succeed in developing any commercial products based upon its long-acting protein technology, including any long-acting versions of human growth hormone, erythropoietin, interferon beta or GLP-1; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from the OCS is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertaint
'/>"/>

SOURCE Modigene Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Modigene Platform Validated in Independent Phase III Trial of CTP Technology
2. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
3. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
4. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
5. Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.
6. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
7. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
8. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
9. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
10. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
11. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), ... , today announced that it will release its unaudited financial ... market on Tuesday, May 28, 2013.  The Company will host ... a.m. EDT (May 28, 2013 at 8:00 p.m. China Standard ... update on recent corporate developments. To access the ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , LISBON, Portugal, September 11 ... Confirms Superiority of the New Intranasal Treatment,for Breakthrough Cancer Pain ... today further demonstrate the efficacy of Instanyl in,management of breakthrough ... of the European Federation of Chapters of the International,Association for ...
... , THOUSAND OAKS, Calif., Sept. 10 ... new data will be presented on the burden of osteoporosis, ... American Society for Bone and Mineral Research (ASBMR) annual meeting ... being evaluated by regulatory bodies in the United States (U.S.), ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8
(Date:5/18/2013)... Los Angeles, Ca (PRWEB) May 18, 2013 ... lot of people. But among the horde of new weight ... the one most talked about. Recent studies about this newest ... to achieve one’s ideal body shape. , Garcinia Cambogia is ... looks like a tamarind. Eating the fruit can suppress a ...
(Date:5/18/2013)... 2013 John Ravera, D.D.S., a Newport ... a new member to his dental team, Courtney Marino. , ... field for over 10 years. She received her degree from ... elected a member of Sigma Pi Alpha, a national honor ... working with patients of all ages, helping them understand the ...
(Date:5/18/2013)... Medical device company, FlexLeg, LLC, last week ... mobility aid with its namesake, the FlexLeg. The device ... alternative that injured individuals can use to walk on ... remain active and walk during a typical 6-8 week recovery ... to ensure those who need the device most are able ...
(Date:5/17/2013)... Lake City, Utah (PRWEB) May 17, 2013 ... by providing their corporate wellness programs to businesses ... This has been achieved through rigorous infrastructure ... a greater capacity for employee interactions via voice ... in helping businesses lower employee healthcare costs ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Johnson & ... it will stop sales of metal-on-metal hip replacements. This ... products drop significantly* amid lawsuits and calls for increased ... ASR hip implant. The Rottenstein Law Group LLP, a ... remove these products from the market and notes that ...
Breaking Medicine News(10 mins):Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 3
... Speaker Nancy Pelosi,issued the following statement today ... Documents are available on the,Administration,s record on fiscal ... our national priorities -- in a fiscally responsible,way, ... "The President has no credibility on matters of ...
... Care for Urgent Health Problems Report Highest Satisfaction When ... Walk-in Clinics , Patient satisfaction with after-hours care for ... own family physician or their physicians after-hours clinic, compared ... health advisory services. According to a survey of 1,227 ...
... WHAT: Each year, seasonal flu kills approximately 36,000 people ... is known about the benefit of influenza vaccine in ... not been large enough to reveal how well the ... , In an article in the October issue of ...
... ITHACA, N.Y. Cornell University will host more than ... campus for the Northeast Wilderness Medical Conference, Sept. 26-28. ... urban disasters by grappling with similar circumstances encountered in ... the Sept. 11, 2001, disaster in New York City ...
... Robust Clinical Data Package Provided in NDA Demonstrates ... Safety of Once-Daily Tramadol Formulation, LAVAL, QC, Sept. ... announced that is has requested a meeting with the ... Drug,Application (NDA) for its once-daily formulation of tramadol. Based ...
... Takeover ... of HCR Manor Care ... WASHINGTON, Sept. 24 A stunning front page,expose by the New York ... by private equity firms across the,country have enriched top executives and buyout ...
Cached Medicine News:Health News:September/October 2007 Annals of Family Medicine tip sheet 2Health News:September/October 2007 Annals of Family Medicine tip sheet 3Health News:September/October 2007 Annals of Family Medicine tip sheet 4Health News:September/October 2007 Annals of Family Medicine tip sheet 5Health News:September/October 2007 Annals of Family Medicine tip sheet 6Health News:September/October 2007 Annals of Family Medicine tip sheet 7Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 2Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 3
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... long history of technology innovation, the new ... seventh-generation device on the VASOVIEW® platform. The ... improves on a familiar platform, combining ease ... new flexibility and finesse into a proven ...
...
... ASR contains primers and a FAM-labeled probe that ... Alexa 532-labeled probe to detect Flu B. In ... Redlabeled probe for a separate sample processing control. ... FAM, Alexa 532 and Texas Red reporter dyes ...
Medicine Products: